Health Condition 1: - Health Condition 2: L209- Atopic dermatitis, unspecified
Conditions
Interventions
Intervention1: Crisaborole 2% ointment: Apply for 2 weeks, 1st follow up, treatment modality replaced if relapsed or not controlled.
Control Intervention1: Betamethasone
valerate 0.1% cream: Apply for
Sponsors
Bankura Sammilani Medical College
Eligibility
Inclusion criteria
Inclusion criteria: Atopic dermatitis patients diagnosed by Hanifin and Rajka criteria. Age more than 5 yrs.
Exclusion criteria
Exclusion criteria: Patients with erythroderma resulting from atopic dermatitis. Those receiving any other immunosuppressives or immunomodulators. Known cases of chronic liver and kidney diseases. Eczema herpeticum cases Patients with psychiatric disorders. Participation in any clinical trial within the last 3 months. Non-consenting patients
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Effectiveness of crisaborole 2% ointment in comparison with betamethasone valerate 0.1% cream in atopic dermatitis patients both active treatment as well as preventive maintenance therapy.Timepoint: 6 months | — |
Secondary
| Measure | Time frame |
|---|---|
| Safety of crisaborole 2% ointment in comparison with betamethasone valerate 0.1%Timepoint: 6 months | — |
Countries
India
Contacts
Public ContactArghyaprasun Ghosh
Bankura Sammilani Medical College
Outcome results
None listed